Storage system for texaphyrin pharmaceutical formulations

作者: Norbert Purro , Hugo Madden , Suzanne Kretchmar Nguyen

DOI:

关键词:

摘要: A packaging system is described for a drug that provides protection from contamination, crystallization and/or degradation of the during storage prior to its use. The does not significantly absorb, react with, or otherwise adversely affect therapeutic effectiveness other excipients components also used preserving drug, particularly containing high-purity texaphyrin metal complexes, by providing product prevents, limits controls reactions can result exposure oxygen light.

参考文章(53)
Gregory W. Hemmi, Jonathan L. Sessler, Tarak D. Mody, Brent Iverson, Petra L. Jansen, Meredith Wright, Darren Magda, Texaphyrins and uses thereof ,(1994)
Jonathan L. Sessler, Tarak D. Mody, Gregory W. Hemmi, Texaphyrin metal complexes having improved functionalization United States Patent and Trademark Office. ,(1995) , 10.26153/TSW/3728
Jonathan L. Sessler, Darren Magda, Vladimir A. Kral, Tarak D. Mody, Gregory W. Hemmi, Texaphyrins substituted with imidazole are provided ,(1997)
Gregory W. Hemmi, Jonathan L. Sessler, Tarak D. Mody, Metal complexes of water soluble texaphyrins ,(1993)
Kathryn W. Woodburn, Stuart W. Young, Qing Fan, Photodynamic therapy of pigment-related lesions ,(1997)
Jonathan L. Sessler, Gregory W. Hemmi, Toshiaki Murai, Aromatic pentadentate expanded porphyrins in magnetic resonance imaging ,(1992)
Leroy Fong Liu, Edmond Joseph LaVoie, Qun Sun, Trisbenzimidazoles useful as topoisomerase I inhibitors ,(1996)
Peter A. Koch, Alexander D. Cross, Emanuel Vogel, Afssaneh Rahbar, Derivatives of porphycene for photodynamic therapy of cancer ,(1991)